Owl biomedical is an emerging company developing microchip-based disposable cell sorting technology that is:
  • Sterilizable,
  • High-speed
  • High-volume
  • High-viability
  • Easy-to-use
  • Disposable
Cells purified using Owl technology can be used for a wide variety of commercial medical applications, including: adoptive immunotherapy for treatment of cancer, stem cell therapies for regenerative medicine (e.g. stroke, limb ischemia, wound healing) and cell-based cancer diagnostics. The technology also has applications in other significantly large fields including basic stem cell and cancer cell research and stem cell sorting for the cosmetic and aesthetic markets. Uniquely combining mechanically-enabled microchips enabled with the world's fastest microvalve and fluorescence-activated sorting of cells, Owl has developed a simple, customizable, disposable sorting cartridge that will ensure safe, sterilizable and rapid purification of specific cells. Owl biomedical is a dedicated business partner offering customized strategic alliances to the Owl platform for commercialization by companies in vertical markets including, cell therapy, cancer diagnostics and basic research. The Company was founded in 2011 and is based in Santa Barbara, California.